Changes in neurologists' treatment preferences for Parkinson's disease in the Netherlands

Constant V M Verschuur; Sven R Suwijn; Rob M A de Bie

doi:10.1016/j.prdoa.2024.100241

Changes in neurologists' treatment preferences for Parkinson's disease in the Netherlands

Clin Park Relat Disord. 2024 Feb 15:10:100241. doi: 10.1016/j.prdoa.2024.100241. eCollection 2024.

Authors

Constant V M Verschuur¹, Sven R Suwijn¹, Rob M A de Bie¹

Affiliation

¹ Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.

Abstract

•Data about treatment preferences for Parkinson's disease (PD) are scarce.•A survey was sent to neurologists in the Netherlands in 2010 and 2021.•In 2021, levodopa was increasingly prescribed for PD.•In 2021, levodopa was increasingly prescribed for younger PD patients.•In 2021, Deep Brain Stimulation became the treatment choice for advanced PD.

Keywords: Parkinson's disease; Questionnaire; Survey; Treatment preference.